Biotech

hurdles hurdles ahead
Biotech

FDA steers CAR-T developers toward randomized superiority trials

Under plans outlined by the Vinay Prasad, the agency will require developers of many CAR-Ts to show superiority over existing treatments.
Nick Paul Taylor Dec 9, 2025 4:33am
NVS

Novartis pens $1.7B atopic disease pact with British biotech

Dec 9, 2025 3:57am
RWE Article heropng

AI and RWE: Enabling Smarter, Faster Choices in Drug Development

Dec 8, 2025 8:00am
Donated human blood conservation in a hospital

Merck mulls PV program’s future while Takeda takes victory lap

Dec 8, 2025 4:30pm
Unknownjpeg

A New Era in Parkinson’s: Solengepras Shifts Beyond Dopamine

Dec 8, 2025 8:00am
Eli Lillys booth at ASH 2025 prominently featuring Jaypirca

Lilly looks to become innovation ‘backbone,’ exec says

Dec 8, 2025 12:05pm